Edison Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 1.16%
- Profit Growth -933.27%
- Ebitda -93.43%
- Net Worth -7.93%
- Total Assets 167.38%
About Edison Biotech
Edison Biotech Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 2014 and has a history of 11 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Jha and Pratibha Jha serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2014PTC263237
-
Company No.
263237
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jan 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Edison Biotech Private Limited offer?
Edison Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Multivitamin Tablets & Capsules, Nutritional Supplements, Digestive System Drugs & Medicines, Esomeprazole Drugs.
Who are the key members and board of directors at Edison Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Jha
|
Director | 08-Jan-2014 | Current |
|
Pratibha Jha
|
Director | 08-Jan-2014 | Current |
Financial Performance of Edison Biotech.
Edison Biotech Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.16% increase. The company also saw a substantial fall in profitability, with a 933.27% decrease in profit. The company's net worth dipped by a decrease of 7.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edison Biotech?
Unlock access to Edison Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edison Biotech?
Unlock and access historical data on people associated with Edison Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edison Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edison Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.